Navigation Links
Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
Date:4/24/2008

EVRY, France, April 24 /PRNewswire/ -- Novagali Pharma, an emerging ophthalmic pharmaceutical company today announced that it has successfully injected the first patient in a Phase I clinical trial using CORTIJECT(R), an ophthalmic injectable emulsion based on EYEJECT(R) technology platform containing a corticosteroid prodrug for the treatment of Diabetic Macular Edema (DME). This trial, which will enrol a total of 15 patients, is designed to evaluate the safety and to observe the efficacy trend of CORTIJECT(R). The patients will be monitored for a period of twelve months following injection. Company's Investigational New Drug Application (IND) to conduct this Phase I clinical trial has been granted by the U.S. Food and Drug Administration (FDA) in January 2008 (cf. Novagali Pharma Press Release issued on January 18th, 2008).

"This first injection in patient is a crucial step toward the clinical development of our state-of-the-art technology for the posterior segment of the eye that can be used to develop new treatments for retinopathies" said Jerome Martinez, Pharm.D., Novagali Pharma Chief Executive Officer. "Thanks to EYEJECT(R) technology, CORTIJECT(R) is a major move with the optimized use of corticosteroids for the back of the eye expected to combine ease of use, sustained release and ocular safety. Administering this emulsion through a single injection can offer real medical value to both physicians and patients."

Investigators for this open-label, dose-escalation study will treat patients suffering from DME with a single intravitreal injection (inside the eye) of CORTIJECT(R) formulation. The trial will include 3 treatment arms with patients receiving one of three doses of Novagali Corticosteroid prodrug. Each administration of CORTIJECT(R) will provide the patient with exposure to the compound for approximately nine months.

About Novagali Pharma : http://www.novagali.com


'/>"/>

SOURCE Novagali Pharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... NEW YORK , Sept. 16, 2014 ... the Hereditary Neuropathy Foundation (HNF) announced today an agreement ... Charcot-Marie-Tooth (CMT) disease and support the development of a ... Pharnext will provide financial support to several HNF,s initiatives ... a specific section in the HNF website featuring  HNF ...
(Date:9/15/2014)... , Sept. 15, 2014 /CNW/ - Health Minister Rona ... will make available for donation over $2.5 million in personal ... aid in the global response to the Ebola outbreak in ... WHO reported a shortage of equipment in the affected countries ... by front-line workers in the affected countries. ...
(Date:9/15/2014)... Sept. 15, 2014  Alere Inc. (NYSE: ALR ... infectious disease, toxicology, cardiology and diabetes products and services, ... by former CEO Ron Zwanziger , filed a ... subsequently sent a letter to Gregg J. Powers ... due diligence in an effort to secure financing to ...
Breaking Medicine Technology:Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 4Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 2Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 3Alere Responds To Letter From Former Executives 2
(Date:9/16/2014)... Lambda Solutions, a leader in cloud-based talent and ... Stewart Rogers on board as the new Director of ... “Product leadership will take Lambda to the next level and ... talent management is at a pivotal moment in healthcare—there has ... development in the past ten years so we’re eager to ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 ADW Diabetes has ... of blood glucose meters and other diabetes testing supplies ... not have the resources to get these much needed supplies ... located in Durham, North Carolina, offers free diabetes information to ... of the adult residents of Durham have diabetes, many of ...
(Date:9/16/2014)... Recently, UWDress.com, an outstanding online supplier of wedding dresses ... offer for cocktail gowns . Now, worldwide customers ... low rate. More importantly, all people that place big ... UWDress.com has promised to provide high quality products only. ... most fashionable items. The company never compromises on customer ...
(Date:9/16/2014)... The rapidly increasing cost of compounded medications ... and PBMs as spending on these specialized drugs has ... a concentrated, patient-specific practice, compounding has become commonplace in ... Services, Inc. (AIS), “Controlling the Cost of Compounded ... what one leading health insurer and its internal PBM ...
(Date:9/16/2014)... Dakota Software , a ... and Sustainability management software, today announced that it ... software platform, MobileWorkflows, at their Annual Users Conference ... allow for on-the-go access to Dakota’s enterprise-level software ... Web Design, MobileWorkflows feature a streamlined user interface, ...
Breaking Medicine News(10 mins):Health News:Stewart Rogers Joins Lambda Solutions as Director of Product Management 2Health News:Stewart Rogers Joins Lambda Solutions as Director of Product Management 3Health News:ADW Diabetes Joins Forces with Durham Diabetes Coalition to Help Local Community 2Health News:ADW Diabetes Joins Forces with Durham Diabetes Coalition to Help Local Community 3Health News:UWDress.com: Cheap Cocktail Gowns For The Global Market 2Health News:Sept. 25 Webinar to Offer Health Plan, Employer Strategies to Control Compounded Medication Costs 2Health News:Mobile EHS Compliance Tools the Focus of Dakota Software’s 2014 Users Conference 2
... number of Australian HIV cases in the past seven years ... in men having sex with men, and some clear geographic ... research published online for the Medical Journal of Australia. ... at the National Centre in HIV Epidemiology and Clinical Research ...
... of quitting smoking, but are prepared to try and lessen ... ,However, after studying healthcare literature, a team of Cochrane ... to this alternative of cutting down the number of cigarettes. ... has been at helping them to stop smoking completely. But, ...
... Researchers have revealed that combining a non-pyrethroid insecticide, ... to be an effective insecticide-repellent synergy against ... ,A combination of the two had proved ... addition of their respective properties. Mosquito nets soaked ...
... Research Foundation (MDRF), in collaboration with the U.K.-based Oxford ... Centre in Chennai . ,For the people ... products, this is a significant development. For now scientific ... Index (the metabolic speed at which food is converted ...
... a sensible diet, exercise and weight control helps people ... Howard Hughes Medical Institute have found that all these ... pathway in the brain. ,This insulin-like pathway ... body. The pathway is activated when insulin and insulin-like ...
... linked bipolar disorder or manic depression with accelerated shrinking of ... condition defined as recurrent episodes of significant disturbance in moods. ... researchers led by Dr. Andrew McIntosh at the University of ... the grey matter in the brain of people with bipolar ...
Cached Medicine News:Health News:HIV Cases Increasing In Australia 2Health News:Chain Smokers Prepared to Lessen Their Daily Cigs Rather Than Quitting 2Health News:Insecticide and Repellent Combo Effective in Eliminating Malarial Mosquitoes 2Health News:A Centre for Glycemic Index Testing Opened in Chennai 2Health News:Sensible Diet, Exercise and Weight Control Increases Longevity 2Health News:Sensible Diet, Exercise and Weight Control Increases Longevity 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: